Clinical Trials Logo

Clinical Trial Summary

This Performance Assessment Study will focus on testing the performance of the VitalSigns Camera under various suboptimal use cases. The software makes it possible to measure the pulse rate (PR) and respiration rate (RR) without the device being in contact with the subject. The software delivers fast and accurate results (in less than one minute). Vital signs camera (VSC) product will be used via a demonstrator app on one of the smartphones during the study sessions (camera of the phone will be used by the VSC product). Devices will be provided by the researchers. The subject will be asked to perform a number of assignments with the software application. The study involves taking a number of measurements of the subject's PR using the VitalSigns Camera software application (which is installed on a smartphone or laptop). In this study only PR is measured and not RR as the latter parameter is not affected by the designed test cases. The total duration of the session will be approximately 1 hour. In total, approximately 30 healthy volunteers will participate in this study.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05465018
Study type Interventional
Source Philips Clinical & Medical Affairs Global
Contact
Status Active, not recruiting
Phase N/A
Start date July 7, 2022
Completion date September 30, 2022

See also
  Status Clinical Trial Phase
Completed NCT01398176 - Immune Benefits From Mushroom Consumption N/A
Completed NCT01248442 - Immune and Metabolic Effects of Vitamin D Supplementation in Healthy Humans Phase 4
Completed NCT00345215 - The Effect of High and Low Sodium Intake on Urinary Aquaporin-2 in Healthy Humans. N/A
Completed NCT01716910 - Effect of Synbiotic on Composition of Human Gut Microbiota and Production of Short and Branched-chain Fatty Acids Phase 0
Completed NCT01398150 - Cranberry Enhances Human Immune Function and Reduces Illness N/A
Completed NCT02291536 - Processing of Salient Emotional Stimuli as a Function of Tetrahydrocannabinol (THC) and Cannabidiol (CBD) N/A